Home » Newsletters » BioWorld Science

BioWorld Science

May 3, 2022

View Archived Issues

OQL-051 shows prophylactic efficacy in models of chemotherapy-induced diarrhea

New EGFR inhibitors discovered at the Dana-Farber Cancer Institute

Storm Therapeutics identifies new METTL3 inhibitors

GlaxoSmithKline synthesizes new MRGPRX2 antagonists

Lilly patents dopamine D1 receptor positive allosteric modulators

Serine/threonine-protein kinase Pim-1 inhibitors identified at Japan Tobacco

Allogeneic colorectal cancer vaccine active against anti-PD-1-resistant colon cancer

S trimer-engaging multivalent protein neutralizes SARS-CoV-2 variants and protects mice

Identification of human MAb that broadly neutralizes sarbecoviruses unveils a crucial CDRH3 motif

Hemispherian closes seed funding to advance preclinical pipeline for cancer

Gilead and Dragonfly collaborate to advance NK cell engager-based immunotherapies

ProfoundBio antibody-drug conjugate PRO-1102 shows potency in vitro and in vivo

Ring Therapeutics describes in vitro system enabling human anellovirus production

Novel TRPC5 inhibitors show potential for the treatment of CKD

Tripartite interactions between nervous system, immune cells and plaques drive atherosclerosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...